chr12-103777864-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001031701.3(NT5DC3):c.1612G>A(p.Gly538Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000719 in 1,613,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001031701.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NT5DC3 | NM_001031701.3 | c.1612G>A | p.Gly538Arg | missense_variant | 14/14 | ENST00000392876.8 | NP_001026871.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NT5DC3 | ENST00000392876.8 | c.1612G>A | p.Gly538Arg | missense_variant | 14/14 | 1 | NM_001031701.3 | ENSP00000376615.3 | ||
NT5DC3 | ENST00000447799.5 | n.331G>A | non_coding_transcript_exon_variant | 3/5 | 2 | ENSP00000413657.1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152172Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000956 AC: 24AN: 251030Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135780
GnomAD4 exome AF: 0.0000595 AC: 87AN: 1461672Hom.: 0 Cov.: 31 AF XY: 0.0000591 AC XY: 43AN XY: 727130
GnomAD4 genome AF: 0.000191 AC: 29AN: 152172Hom.: 0 Cov.: 33 AF XY: 0.000256 AC XY: 19AN XY: 74348
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at